Brian Freeman

Brian Freeman has extensive work experience in the pharmaceutical and biotech industry. Brian is currently serving as the Vice President and Product Team Leader for Malignant Hematology at ImmunoGen, Inc., where they lead a team responsible for the development and implementation of the lifecycle strategy for IMGN632. Prior to this, Brian worked at Foghorn Therapeutics, Inc. as the Head of Commercial Strategy, overseeing global commercialization preparation for the late-stage pipeline. Brian also served as the Principal at Freeman Biotech Consulting, providing consulting services to small biotech companies in areas such as lifecycle management and launch planning. Brian has also held various positions at Genentech, including Head of Pipeline Marketing, Access, & National Accounts and Director of Xolair Sales. Additionally, they have experience working at McKinsey & Company as a Research Analyst, Nanosphere as an Engineer, Northwestern University as a Research Intern, and Johnson & Johnson - Ethicon Endo-Surgery as a Design Engineer.

Brian Freeman earned a Bachelor of Science degree in Biomedical Engineering and Economics from Northwestern University in 2000. Brian went on to complete their Master of Business Administration degree specializing in Business and Health Sector Management from Duke University - The Fuqua School of Business in 2004.